Neuropsychological aspects of nicotine craving;Aspectos neuropsicológicos del craving por la nicotina

Adicciones

Volumn 23, Issue 2, 2011, Pages 111-123

  Muñoz, Miguel Ángel ^a   Sanjuan, Rocío ^a   Fernández Santaella, Ma Carmen ^b   Vila, Jaime ^b   Montoya, Pedro ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Craving; Neuropsychological mechanisms; Nicotine dependence; Smoking; Theoretical models

Indexed keywords

ARTICLE; HUMAN; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL; TOBACCO DEPENDENCE;

HUMANS; MODELS, PSYCHOLOGICAL; TOBACCO USE DISORDER;

EID: 79958842109     PISSN: 02144840     EISSN: None     Source Type: Journal    
DOI: 10.20882/adicciones.154     Document Type: Review

References (137)

1. Allen, S.S., Bade, T., Hatsukami, D. y Center, B. (2008). Craving, withdrawal, and smoking urges on days immediately prior to smoking relapse. Nicotine & Tobacco Research, 10, 35-45.
2. Altner, N. (2002). Mindfulness Practice and Smoking Cessation: The Essen Hospital Smoking Cessation Study. Journal for Meditation and Meditation Research, 2, 9-18.
3. Ashelman, M.W. (2000). Stop Smoking Naturally. New Canaan, Connecticut: Keats Publishing Inc.
4. Antón, R.F. (1999). What is craving? Models and implications for treatment. Alcohol Research and Health, 23, 165-73.
5. Baker, T.B., Piper, M.E., McCarthy, D.E., Majeskie, M.R. y Fiore, M.C. (2004). Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychological Review, 111, 33-51.
6. Baker, T.B., Morse, E. y Sherman, J.E. (1986). The motivation to use drugs: A psychobiological analysis of urges. Nebraska Symposium on Motivation, 34, 257-323.
7. Balfour, D. J. K. (2005). The neurobiology of tobacco dependence: A preclinical perspective on the role of the dopamine projections to the nucleus. Nicotine and Tobacco Research, 6, 899-912.
8. Baxter, M.G. y Murray, E.A. (2002). The Amygdala and Reward. Nature Reviews Neuroscience 3, 563-573.
9. Benowitz, N.L. (1998). Pharmacology aspects of cigarette smoking and nicotine addiction. National England Journal of Medicine, 319, 1318-1330.
10. Benowitz, N.L. (2008a). Neurobiology of nicotine addiction: Implications for smoking cessation treatment. The American Journal of Medicine, 121(supl. 1), S3-S10.
11. Benowitz, N.L. (2008b) Clinical Pharmacology of Nicotine: Implications for Understanding, Preventing, and Treating Tobacco Addiction. Clinical Pharmacology y Therapeutics, 83, 531-541.
12. Berridge, K. C. (2007). The debate over dopamine ́s role in reward: the case for incentive salience. Psychopharmacology, 191, 391-431.
13. Berridge, K. C. y Robinson, T. E. (1998). What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Research Reviews, 28, 309-369.
14. Berridge, K.C., Robinson, T.E. y Aldridge, J.W. (2009). Dissecting components of reward: 'liking', 'wanting', and learning. Current Opinion in Pharmacology, 9, 65-73.
15. Blasco, J., Martínez-Raga, J., Carrasco, E. y Didia-Attas, J. (2008). Atención y craving o ganas compulsivas. Avances en su conceptualización y su implicación en la prevención de recaídas. Adicciones, 20, 365-376.
16. Bond, A. y Lader, M. (1974). The use of analogue scales in rating subjective feelings. British Journal of Medical Psychology, 47, 211-218.
17. Brody, A. L., Mandelkern, M. A., London, E. D., Childress, A. R., Lee, G. S., Bota, R. G.,... Jarvik, M. E. (2002). Brain metabolic changes during cigarette craving. Archives of General Psychiatry, 59, 1162-1172.
18. Brown, K.W. y Ryan, R.M. (2003). The benefits of being present: mindfulness and its role in psychological well-being. Journal of personality and social psychology, 84, 822-848.
19. Cardinal, R., Parkinson, J., Hall, J. y Everitt, B. (2002). Emotion and motivation: the role of the amygdala, ventral striatum and prefrontal cortex. Neuroscience and Biobehavioral Reviews, 26, 321-352.
20. Cepeda-Benito, A. (1993). A meta analytical review of the efficacy of nicotine chewing gum in smoking treatment programs. Journal of Consulting and Clinical Psychology, 61, 822-830.
21. Chiamulera, C. (2005). Cue reactivity in nicotine and tobacco dependence: a "multiple-action" model of nicotine as a primary reinforcement and as an enhancer of the effects of smokingassociated stimuli. Brain Research Reviews, 48, 74-97.
22. Cinciripini, P.M., Lapitsky, L., Seay, S., Wallfisch, A., Meyer, W.J. y van Vunakis, H. (1995). A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high-and low-anxiety smokers. Journal of Clinical Psychopharmacology, 15, 182-191.
23. Conklin, C. A., Clayton, R. R., Tiffany, S. T., y Shiffman, S. (2004). Introduction to concepts and measurement of the emergence of tobacco dependence: The Tobacco Etiology Research Network. Addiction, 99 (Suppl. 1), 1-4.
24. Covey, L.S., Glassman, A.H., Stetner, F., Rivelli, S. y Stage, K. (2002). A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. American Journal of Psychiatry,159, 1731-7.
25. Davis, J.M., Fleming, M.F., Bonus, K.A., y Baker, T.B. (2007). A pilot study on mindfulness based stress reduction for smokers BMC Complementary and Alternative Medicine, 7, 1-7.
26. Davis, M. (1992). The role of the amygdala in conditioned fear. En J. P. Aggleton (Ed.), The amygdala: Neurobiological aspects of emotion, memory, and mental dysfunction (pp. 255-305). New York: Wiley-Liss.
27. Di Ciano, P., y Everitt, B. J. (2004). Direct Interactions between the Basolateral Amygdala and Nucleus Accumbens Core Underlie Cocaine-Seeking Behavior by Rats. Journal of Neuroscience, 24, 7167-7173.
28. Drobes, D. J. (2002). Cue reactivity in alcohol and tobacco dependence. Alcoholism: Clinical and Experimental Research, 26, 1928-1929.
29. Drummond, D.C. (2001) Theories of drug craving ancient and modern. Addiction, 96, 33-46.
30. Drummond, D. C., Tiffany, S. T., Glautier, S. y Remington, B. (1995). Addictive behaviour: Cue exposure theory and practice. UK: Wiley & Sons.
31. Due, D. L., Huettel, S. A., Hall, W. G. y Rubin, D. C. (2002). Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: Evidence from functional magnetic resonance imaging. American Journal of Psychiatry, 159, 954-960.
32. Dunn, L. T., y Everitt, B. J. (1988). Double dissociations of the effects of amygdala and insular cortex lesions on conditioned taste aversion, passive avoidance, and neophobia in the rat using the excitotoxin ibotenic acid. Behavioral Neuroscience, 102, 3-23.
33. Ebbert, J.O., Croghan, I.T., Sood, A., Schroeder, D.R., Hays, J.T. y Hurt, R.D. (2009). Varenicline and bupropion sustained-release combination therapy for smoking cessation. Nicotine Tobacco Research. Advance online publication. DOI: 10.1093/ntr/ntn031.
34. Everitt, B. J., Parkinson, J. A., Olmstead, M. C., Arroyo, M., Robledo, P., y Robbins, T.W. (1999). Associative processes in addiction and reward: The role of amygdalaventral striatal subsystems. Annals of the New York Academy of Sciences, 877, 412-438.
35. Everitt, B. J., y Robbins, T. W. (2005). Neural systems of reinforcement for drug addiction: From actions to habits to compulsion. Nature Neuroscience, 8, 1481-1489.
36. Everitt, B.J. y Robbins, T.W. (1992). Amygdala-ventral striated interactions and reward related processes. En L. Aggleton (Ed.), The amygdala: Neurobiological aspects of emotion, memory, and mental dysfunction (pp. 401-429). New York: Wiley.
37. Field, M., Rush, M., Cole, J. y Goudie, A.J. (2007). The smoking Stroop and delay discounting in smokers: effects of environmental smoking cues. Journal Psychopharmacology, 21, 603-610
38. Fiore, M.C., Jaén, C.R., Baker, T.B., Bailey, W.C., Benowitz, N.L., Curry, S.J.,.... Wewers, M.E. (2008). Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. http://www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf
39. Frazer, A. (2001). Serotonergic and Noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies. Journal of Clinical Psychiatry, 62, 16-23.
40. Gifford, E.V., Kohlenberg, B.S., Hayes, S.C., Antonuccio, D.O., Piasecki, M.M., Rasmussen-Hall, M. y Palm, K.M. (2004). Acceptancebased treatment for smoking cessation. Behaviour Therapy, 35, 689-705.
41. Glassman, A.H., Covey, L.S., Dalack, G.W., Stetner, F., Rivelli, S.K., Fleiss, J. y Cooper, T.B. (1993). Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clinical Pharmacology Therapy, 54, 670-679.
42. Gloria, R., Angelos, L., Schaefer, H.S., Davis, J.M., Majeskie, M., Richmond, B.S.,... Baker, T.B. (2009). An fMRI investigation of the impact of withdrawal on regional brain activity during nicotine anticipation. Psychophysiology, 46, 681-693.
43. Goldstein, R.Z. y Volkow, N.D. (2002). Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. American Journal of Psychiatry, 159, 1642-1652.
44. Gourlay, S.G. y Benowitz, N.L. (1995). Is clonidine an effective smoking cessation therapy? Drugs, 50, 197-207.
45. Gray, M.A. y Critchley, H.D. (2007). Interoceptive Basis to Craving. Neuron, 54, 183-186,
46. Groenewegen, H.J., Berendse, H.W. y Haber, S.N. (1993) Organization of the output of the ventral striatopallidal system in the rat: ventral pallidal efferents. Neuroscience, 57, 113-142.
47. Hatsukami, D. K., Ebbert, J. O., Anderson, A., Lin, H., Le, C. y Hecht, S.S. (2007). Smokeless tobacco brand switching: A means to reduce toxicant exposure? Drug and Alcohol Dependence, 87, 217-224.
48. Henningfield, J.E. (1995). Nicotine medications for smoking cessation. New England Journal of Medicine, 333, 1196-1203.
49. Henningfield, J.E. Fant, R.V. y Buchhalter, A.R. (2005). Pharmacotherapy for nicotine dependence. CA Cancer Journal Clinical, 55, 281-99.
50. Herrero, F. J. y Moreno, J. (2004). Tratamientos combinados del tabaquismo: psicológicos y farmacológicos. Adicciones, 16, 285-301.
51. Hughes, J.R., Stead, L.F. y Lancaster, T. (2007). Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews, 1, CD000031.
52. Iraurgi, I. y Corcuera, N. (2008). Craving: concepto, medición y terapéutica. Norte de Salud Mental, 32, 9-22.
53. Jané, M. (2004). Mujeres y tabaco: aspectos principales específicos de género. Adicciones, 16, 115-130.
54. Janse van Rensburg, K., Taylor, A.H. y Hodgson, T. (2007). The effects of exercise on regional brain activation in response to smoking cues during temporary abstinence from smoking [resumen]. 12th European Congress of Sport Psychology, Halkidiki, Greece.
55. Janse van Rensburg, K., Taylor, A.H. y Hodgson, T. (2008) The effects of acute exercise on attentional biases to smoking related stimuli during temporary abstinence from smoking. Addiction, 104, 1910-1917.
56. Jiménez, L., Bascarán, M. T., García-Portilla, M.P. Sáiz, M. A., Bousoño, M. y Bobes, J. (2004). La nicotina como droga. Adicciones, 16 (Supl.2), 143-153
57. Joel, D. y Weiner, I. (2000). The connections of the dopaminergic system with the striatum in rats and primates: An analysis with respect to the functional and compartmental organization of the striatum, Neuroscience, 96, 451-474.
58. Jorenby, D.E., Hays, J.T., Rigotti, N.A., Azoulay, S., Watsky, E.J., Williams K.E.,... Reeves, K.R. (2006). Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA, 296, 56-63.
59. Kalivas, P. W. y Volkow, N. D. (2005). The Neural Basis of Addiction: A Pathology of Motivation and Choice. American Journal of Psychiatry, 162, 1403-1413.
60. Kavanagh, D. J., Sitharthan, G., Young, R. M., Sitharthan, T., Saunders, J. B., Shockley, N. y Giannopoulos, V. (2006). Addiction of cue exposure to cognitive-behaviour therapy for alcohol misuse: a randomized trial with dysphoric drinkers. Addiction, 101, 1106-1116.
61. Kelley, A. E. (2004). Memory and Addiction: Shared Neural Circuitry and Molecular Mechanisms. Neuron, 44, 161-179.
62. Kober, H., Kross, E.F., Mischel, W., Hart, C.L. y Ochsner, K.N. (2010). Regulation of craving by cognitive strategies in cigarette smokers. Drug and Alcohol Dependence, 106, 52-55.
63. Lerman, C., Niaura, R., Collins, B. N., Wileyto, P., Audrain-McGovern, J., Pinto, A.,... Epstein, L. H. (2004). Effect of bupropion on depression symptoms in a smoking cessation clinical trial. Psychological Addictive Behaviour, 18, 362-366.
64. Lim, H. K., Pae, C. U., Joo, R. H., Yoo, S. S., Choi, B. G., Kim, D. J.,... Lee, C.U. (2005). fMRI investigation on cue-induced smoking craving. Journal of Psychiatric Research, 39, 333-335.
65. Livingstone, P.D. y Wonnacott, S. (2009). Nicotinic acetylcholine receptors and the ascending dopamine pathways, Biochemical Pharmacology, 78, 744-55
66. Ludwig, A.M. y Wikler, A. (1974). Craving and relapse to drink. Quarterly Journal of Studies on Alcoholism, 35, 108-130.
67. Merikle, E.P (1999). The subjective experience of craving: an exploratory analysis. Substance Use and Misuse, 34, 1101-1115
68. Markou, A., Weiss, F., Gold, L.H., Caine, B., Schulteis, G. y Koob, G.F. (1993). Animal models of drug craving. Psychopharmacology, 112, 63-182.
69. Marlatt, G. A. (1985). Relapse prevention: theoretical rationale and overview of the model. En Marlatt, G. A. y Gordon, J. R. (Eds.). Relapse prevention, (pp. 3-70). New York: The Guilford Press.
70. Matsumoto, K., Suzuki, W. y Tanaka, K. (2003). Neuronal correlates of goal-based motor selection in the prefrontal cortex. Science, 301, 229-32.
71. Mihalak, K.B., Carroll, F.I. y Luetje, C.W. (2006). Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Molecular Pharmacology, 70, 801-5.
72. Miller, E.K., y Cohen, J.D. (2001). An integrative theory of prefrontal cortex function. Annual Reviews Neuroscience, 24, 167-202.
73. Muñoz, M.A., Baena, A. y Cepeda-Benito, A. (2006). Revisión de tratamiento de tabaco en mujeres. Clínica y Salud, 17, 91-117.
74. Muñoz, M.A., Martinez, J.A. Fernández, M.C., Cepeda-Benito, C. y Vila, J. (2010). Two Scales to Evaluate Cocaine Craving. Substance Use y Misuse, 45, 1303-1318.
75. Muñoz, M.A., Viedma-del-Jesus, M.I., Fernández-Santaella, M.C., Peralta-Ramírez M.I, Cepeda-Benito A. y Vila, J. (2009). Assessment of tobacco craving by means of the affective image visualization paradigm. Motivation and Emotion. Advance online publication. DOI-10.1007/s11031-009-9145.
76. Murphy, J.K., Edwards, N.B., Downs, A.D., Ackerman, B.J. y Rosenthal, T.L. (1990). Effects of doxepin on withdrawal symptoms in smoking cessation. American Journal Psychiatry, 147, 1353-1357.
77. Nana, A. y Praditsuwan, R. (1998). Clonidine for smoking cessation. Journal of The Medical Association of Thailand, 81, 87-93.
78. Napier, T.C., Mitrovic, I., Churchill, L., Klitenick, MA, Lu, X.Y. y Kalivas, P.W. (1995). Substance P in the ventral pallidum: projection from the ventral striatum, and electrophysiological and behavioral consequences of pallidal substance P. Neuroscience, 69, 59-70.
79. Naqvi, N. H., Rudrauf, D., Damasio, H. y Bechara, A. (2007). Damage to the insula disrupts addiction to cigarette smoking. Science, 315(5811), 531-534.
80. Niaura, R. Spring, B. Borrelli, B. Hedeker, D. Goldstein, M.G., Keuthen, N.,... Abrams, D.B. (2002). Multicenter trial of fluoxetine as an adjunct to behavioural smoking cessation treatment. Journal of Consulting and Clinical Psychology, 70, 887-896.
81. Niaura, R. (2008). Nonpharmacologic Therapy for Smoking Cessation: Characteristics and Efficacy of Current Approaches. American Journal of Medicine, 121, S11-S19.
82. Niaura, R., Abrams, D. B., Shadel, W. G., Rohsenow, D. J., Monti, P. M. y Sirota, A. D. (1999). Cue exposure treatment for smoking relapse prevention: a controlled clinical trial. Addiction, 94, 685-695.
83. Nides, M. (2008). Update on pharmacologic options for smoking cessation treatment. American Journal of Medicine, 121, S20-S31.
84. O'Connor, E.C., Parker, D., Rollema, H. y Mead, A.N. (2010). The r442 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats. Psychopharmacology, 208, 365-376.
85. OMS-Expert Committee on Mental Health and Alcohol. (1955). The "craving" for alcohol. Quarterly Journal of Studies on Alcohol, 16, 33-66.
86. Parkinson, J.A., Crofts, H.S., McGuigan, M., Tomic, D.L., Everitt, B.J. y Roberts, A.C. (2000). The role of the primate amygdala in conditioned reinforcement. Journal of Neuroscience 21, 7770-7780.
87. Parsons, A.C., Shraim, M., Inglis, J., Aveyard, P. y Hajek, P. (2009). Interventions for preventing weight gain after smoking cessation. Cochrane Database of Systematic Reviews 1, CD006219.
88. Pérez de los Cobos, J. C., Valderrama, J. C., Cervera, G. y Rubio, G. (2006). Tratado SET de trastornos adictivos (1 ed.). Madrid: Medica Panamericana.
89. Pettinati, H.M., Volpicelli, J.R., Kranzler, H.R., Luck, G., Rukstalis, M.R. y Cnaan, A. (2000). Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcoholism Clinical and Experimental Research, 24, 1041-1049.
90. Pinet, C. (2003). Tratamiento del tabaquismo. En Bobes J, Casas M, Gutiérrez M (eds.). Manual de evaluación y tratamiento de drogodependencias. Barcelona: Ars Medica.
91. Pitkänen A. (2000). Connectivity of the rat amygdaloid complex. En Aggleton (Ed.), The Amygdala: A Functional Analysis, (pp. 31-115). UK: Oxford Univ.
92. Placzek, A.N., Zhang, T.A. y Dani, J.A. (2009) Nicotinic mechanisms influencing synaptic plasticity in the hippocampus. Acta Pharmacologica Sinica. 30, 752-60.
93. Poulos, C. X., Hinson, R. E. y Siegel, S. (1981). The role of Pavlovian processes in drug tolerance and dependence: implications for treatment. Additive Behaviours, 6, 205-211.
94. Prochaska, J.J., Delucchi, K. y Hall, S.M. (2004). A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology, 72, 1144-1156.
95. Quesada, M., Carreras, J. M. y Sánchez, L. (2002). Recaída En El Abandono Del Consumo De Tabaco: Una Revisión. Adicciones,14, 65-78.
96. Ray, R., Tyndale, R.F. y Lerman, C. (2009). Nicotine dependence pharmacogenetics: Role of genetic variation in nicotinemetabolizing enzymes. Journal Neurogenetics, 23, 1-10.
97. Robbins, T.W. y Everitt, B.J. (1996). Neurobehavioural mechanisms of reward and motivation. Current Opinion Neurobiology, 6, 228-236.
98. Robinson, T. E. y Berridge, K. C. (1993). The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research Reviews, 18, 247-291.
99. Roesch, M.R. y Olson, C.R. (2004). Neuronal activity related to reward value and motivation in primate frontal cortex. Science, 304, 307-10.
100. Rose, J.E. (2007). Multiple brain pathways and receptors underlying tobacco addiction. Biochemical Pharmacology, 74, 1263-1270.
101. Rosse, R.B., Johri, S., Kendrick, K., Hess, A.L., Alim, T.N., Miller, M.M. y Deutsch, S.I. (1997). Preattentive and attentive eye movements during visual scanning of a cocaine cue: Correlation with intensity of cocaine craving. Journal of Neuropsychiatry and Clinical Neurosciences, 9, 91-93.
102. Sáiz, P. A., García-Portilla, M. P., Martínez, S., Bascarán, M. T., Paredes, B. y Bobes, J. (2004). Tratamiento farmacológico. Psicofármacos. Adicciones, 16 (Supl. 2), 275-286
103. Sayette, M. A., Shiffman, S., Tiffany, S. T., Niaura, R. S., Martin, C. S. y Shadel, W. G. (2000) The measurement of drug craving, Addiction, 95 (Suppl. 2), S189-S210.
104. Sayette, M. y Hufford, M. (1994). The effects of cue exposure and deprivation in cognitive resources in smokers. Journal of Abnormal Psychology, 103, 812-818.
105. Schneider, N.G., Lunell, E., Olmstead, R.E. y Fagerstrom, K.O. (1996). Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems. Clinical Pharmacokinetics, 31, 65-80.
106. Selden, N. R. W., Everitt, B. J., Jarrard, L. E. y Robbins, T. W. (1991). Complementary roles for the amygdala and hippocampus in aversive conditioning to explicit and contextual cues. Neuroscience, 42, 335-350.
107. Shadel, W., Niaura, R. y Abrams, D. (2001). Does completing a craving questionnaire promote increased smoking craving? An experimental investigation. Psychology of Addictive Behaviors, 15, 265-267.
108. Sharma, A. y Brody, A.L. (2009). In vivo Brain Imaging of Human Exposure to Nicotine and Tobacco. En Henningfield, J.E., London E.D. and Pogun, S. (Eds) Nicotine Psychopharmacology Handbook of Experimental Pharmacology 192, Berlin: Heidelberg.
109. Shidara, M. y Richmond, B.J. (2002). Anterior cingulate: single neuronal signals related to degree of reward expectancy. Science, 296, 1709-1711.
110. Shiffman, S. (1984). Coping with temptations to smoke to smoke. Journal of consulting and clinical psychology, 52, 261-307.
111. Shiffman, S., West, R. J., y Gilbert, D.G. (2004). Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine and Tobacco Research, 6, 599-614.
112. Siegel, S. (1979). The role of conditioning in drug tolerance and addiction. En J.D. Keehn (Ed.). Psychopathology in animals: research and treatment implications. New York: Academic Press.
113. Sociedad Española de Psiquiatría (2003). Consenso de la Sociedad Española de Psiquiatría sobre diagnóstico y tratamiento del alcoholismo y otras adicciones. Barcelona: Euromedice, 2003.
114. Stewart, J., De Wit, H. y Eilkelboom, R. (1984). Role of unconditioned and conditioned drug effects in self-administration of opiates and stimulants. Psychological Review, 91, 251-268.
115. Stoehr, J. D. (2006). The neurobiology of Addiction. Philadelphia: Chelsea House.
116. Taylor, A.H. y Katomeri, M. (2007). Walking reduces cue-elicited cigarette cravings and withdrawal symptoms, and delays ad libitum smoking. Nicotine & Tobacco Research, 9, 1-8.
117. Tejero, A., Trujols, J. y Siñol, N. (2003). Evaluación del craving a la cocaína. En Pérez de los Cobos, J. (Ed.): Instrumentos clínicos para la evaluación de la dependencia a la cocaína. Barcelona: Citran-Ars Medica.
118. Tiffany, S. T. (1990). A cognitive model of drug urges and drug-use behavior: Role of automatic and nonautomatic processes. Psychological Review, 97, 147-168.
119. Tiffany, S. T. (1997). New perspectives on the measurement, manipulation and meaning of drug craving. Human Psychopharmacology: Clinical and Experimental, 12, 103-113.
120. Tiffany, S.T. (1995). The role of cognitive factors in reactivity to drug cues. En Drummond, D.C., Tiffany, S.T., Glautier, S.P. and Remington, B. (Eds.): Addictive behaviour: Cue Exposure, Theory and Practice (pp. 137-169). Chichester, England: John Wiley.
121. Tiffany, S.T. y Drobes, D.J. (1991). The development and initial validation of a questionnaire of smoking urges. British Journal of addiction, 86, 1467-1476.
122. Tiffany, S.T. (1992). A critique of contemporary urge and craving research: methodological, psychometric, and theoretical issues. Advances in Behaviour Research and Therapy, 14, 123-139.
123. Tonstad, S. (2006). Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist. Journal Cardiovascular Nursing, 21, 433-436.
124. U.S. Department of Health & Human Services. (2008). Treating Tobacco Use and Dependence:2008 Update. A report of the Surgeon General. Rockville, MD: Public Health Service.
125. Ussher, M.H., Taylor, A. y Faulkner, G. (2008). Exercise interventions for smoking cessation. Cochrane Database of Systematic Reviews, 4, CD002295.
126. Vidrine, J.I., Businelle, M.S., Cinciripini, P., Li, Y., Marcus, M.T., Waters, A.J., Reitzel, L.R. y Wetter, D.W. (2009) Associations of Mindfulness with Nicotine Dependence, Withdrawal, and Agency, Substance Abuse, 30, 318-327.
127. Villegier, A. S., Salomon, L., Blanc, G., Godeheu, G., Glowinski, J. y Tassin, J. P. (2006). Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in mice. European Journal of Neuroscience, 24, 1359-1365.
128. Watkins, S. S., Koob, G. F. y Markou, A. (2000). Neural mechanisms underlying nicotine addiction: Acute positive reinforcement and withdrawal. Nicotine and Tobacco Research, 2, 19-37.
129. Weiss, F. (2005). Neurobiology of craving, conditioned reward and relapse. Current Opinion of Pharmacology, 5, 9-19. West, R.J. (2000) Signs and symptoms during the acute phase of smoking cessation. International Journal of Neuropsychopharmacology, 3, S59.
130. Wilson, S. J., Sayette, M. A., y Fiez, J. A. (2004). Prefrontal responses to drug cues: a neurocognitive analysis. Nature Neuroscience, 7, 211-214.
131. Winhusen, T., Somoza, E., Harrer, J., Mezinskis, J., Montgomery, M., Goldsmith, R.,... Elkashef, A. (2005). A placebo-controlled screening trial of tiagabine, sertraline, and donepezil as cocaine dependence treatments. Addiction, 100 (Suppl.1), 68-77.
132. Wise, R.A. y Bozarth, M.A. (1987). A Psychomotor stimulant theory of addiction. Psychological Review, 94, 469-492.
133. Wise, R.A. (2004). Drive, Incentive, and Reinforcement: The Antecedents and Consequences of Motivation. Nebraska Symposium on Motivation (Series), 50, 159-195.
134. Wooltorton, J.R.A., Pidoplichko, V.I., Broide, R.S. y Dani, J.A. (2003). Differential Desensitization and Distribution of Nicotinic Acetylcholine Receptor Subtypes in Midbrain Dopamine Areas. Journal of Neuroscience, 23, 3176-3185.
135. Xi, Z.X., Spiller, K. y Gardner, E.L. (2009). Mechanism-based medication development for the treatment of nicotine dependence. Acta Pharmacologica Sinica, 30, 723-739.
136. Zanetti, L., Picciotto, M. R. y Zoli, M. (2007). Differential effects of nicotinic antagonists perfused into the nucleus accumbens or the ventral tegmental area on cocaine-induced dopamine release in the nucleus accumbens of mice. Psychopharmacolog., 190, 189-199.
137. Zhang, T., Zhang, L., Liang, Y., Siapas, A.G., Zhou, F.M. y Dani, J.A. (2009). Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine. Journal of Neuroscience, 29, 4035-43.